Manager × security

JACOBS LEVY EQUITY MANAGEMENT, INC ELV holdings history

Who else holds this security?

ELEVANCE HEALTH INC · CUSIP 036752103 · CIK 884414

This is the oldest quarter open without an account, so changes against the quarter before it are withheld. Sign in to see them.
Citable facts

As of 2026-06-30, JACOBS LEVY EQUITY MANAGEMENT, INC reported 62.12K ELV (shares), valued at $24.02M, or 0.09% of its reported non-derivative portfolio. Filed 2026-08-14.

Verify history & sources
Portfolio weight and quantity history
Reported portfolio weight
0.09%
Shares
62.12K
62,115
Reported value
$24.02M
USD

Shares decreased 29.95%; reported value decreased 7.46%, and weight changed -0.02 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.

Left: % · Right: Shares · Independently scaled axes

Exact data and methodology

Axes scale independently; a crossing does not mean equal values. Weight uses each quarter's total reported non-derivative value. Same CUSIP; missing quarters are gaps, not zero. Revised history may include later disclosures.

QuarterWeightQuantitySource
Q2 20260.09%62,115SEC filingFiled Aug 14, 2026Combination report
Q1 20260.11%88,672SEC filingFiled May 15, 2026Combination report
Q4 20250.14%102,699SEC filingFiled Feb 13, 2026Combination report
Q3 20250.12%92,100SEC filingFiled Nov 17, 2025Combination report
Q2 20250.28%186,090SEC filingFiled Aug 14, 2025Combination report
Q1 20250.68%393,669SEC filingFiled May 15, 2025Combination report
Q4 20240.86%658,658SEC filingFiled Feb 14, 2025Combination report
Q3 20241.12%556,352SEC filingFiled Nov 14, 2024Combination report
Q2 20240.90%400,904SEC filingFiled Aug 14, 2024Combination report
Q1 20240.86%371,992SEC filingFiled May 15, 2024Combination report
Q4 20230.59%250,306SEC filingFiled Feb 14, 2024Combination report
Q3 20230.39%149,600SEC filingFiled Nov 17, 2023Combination report

History & evidence by quarter

QuarterWeightQuantityValueChange explainedSource
Q3 20230.39%149,600$65.14MThe prior quarter is outside the free window. Sign in for the comparison.SEC filing
Filed Nov 17, 2023
Q4 20230.59%250,306$118.03MShares increased 67.32%; reported value increased 81.20%, and weight changed +0.20 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing
Filed Feb 14, 2024
Q1 20240.86%371,992$192.89MShares increased 48.61%; reported value increased 63.42%, and weight changed +0.27 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing
Filed May 15, 2024
Q2 20240.90%400,904$217.23MShares increased 7.77%; reported value increased 12.62%, and weight changed +0.04 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing
Filed Aug 14, 2024
Q3 20241.12%556,352$289.30MShares increased 38.77%; reported value increased 33.18%, and weight changed +0.22 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing
Filed Nov 14, 2024
Q4 20240.86%658,658$242.98MShares increased 18.39%; reported value decreased 16.01%, and weight changed -0.26 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing
Filed Feb 14, 2025
Q1 20250.68%393,669$171.23MShares decreased 40.23%; reported value decreased 29.53%, and weight changed -0.18 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing
Filed May 15, 2025
Q2 20250.28%186,090$72.38MShares decreased 52.73%; reported value decreased 57.73%, and weight changed -0.40 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing
Filed Aug 14, 2025
Q3 20250.12%92,100$29.76MShares decreased 50.51%; reported value decreased 58.89%, and weight changed -0.16 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing
Filed Nov 17, 2025
Q4 20250.14%102,699$36.00MShares increased 11.51%; reported value increased 20.97%, and weight changed +0.02 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing
Filed Feb 13, 2026
Q1 20260.11%88,672$25.96MShares decreased 13.66%; reported value decreased 27.89%, and weight changed -0.03 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing
Filed May 15, 2026
Q2 20260.09%62,115$24.02MShares decreased 29.95%; reported value decreased 7.46%, and weight changed -0.02 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing
Filed Aug 14, 2026
JACOBS LEVY EQUITY MANAGEMENT, INC · ELEVANCE HEALTH INC

Take these holdings further.

This page includes 12 of 12 reported holdings. Sign in to look up the full history beyond 3 years, use advanced screening & filtering, download CSV, and get the complete set through the Akkru API.

  • Download CSV
  • Earlier quarters
  • Advanced screening & filtering
  • API & AI access
Already have an account?

New accounts get free API credits to explore data beyond ownership filings.

For AI agents & developers

The initial HTML of this page carries its exact data as script#research-data (JSON): values, units, scope, preview limits and SEC sources. Read it directly, no script or API key needed; script#research-access says what needs an account.

Without an account: the last 3 years, with the row caps stated on the page. A free account opens all history on file on these pages and the CSV of what a page shows. Rows beyond the caps and bulk retrieval go through the authenticated API / MCP.

MCP  https://api.akkrudata.ai/mcp

get_institutional_portfolio
{"cik":"884414","quarter":"2026Q2","cusip":"036752103"}

get_institutional_manager_history
{"cik":"884414","page_size":100}

Connect to MCP with OAuth and follow the returned pagination. Credits and usage limits depend on the account.

MCP endpoint
https://api.akkrudata.ai/mcp
API / MCP documentation
/documents
llms.txt
/llms.txt
Sources, coverage & how to read this data

Figures are as reported to the SEC and merged with later amendments where Akkru could match them. Preview limits apply to what is listed, not to the totals, which come from the complete reported data. Nothing is zero-filled: a missing quarter or month is shown as missing.

13F reports quarter-end long positions in securities traded on US exchanges, filed by managers holding at least $100 million of such securities; it is not the manager's full portfolio, not assets under management, and value changes are not returns. Weights use the reported total value as denominator. Option rows show notional value, not premium or net exposure. Amendments are merged into the quarter when Akkru could match them.